During the past decade, Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ" are "Hemophilia A" (1 trials), "Hemophilia A With Inhibitor" (1 trials), "Hemophilia B With Inhibitor" (1 trials), "Moderate Hemophilia A" (1 trials) and "Severe Hemophilia A" (1 trials). Many other conditions were trialed in "Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ" in a lesser frequency.

Most popular intervention types in "Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials), "MarzAA" (1 trials), "UTTR1147A" (1 trials), "UTTR1147A Placebo" (1 trials) and "Vedolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".